Hospitalization for psychiatric illness among community-dwelling elderly persons in 1992 and 2002
- PMID: 18757599
- DOI: 10.1176/ps.2008.59.9.1046
Hospitalization for psychiatric illness among community-dwelling elderly persons in 1992 and 2002
Abstract
Objective: The authors evaluated the evolution of inpatient care for psychiatric illness in 1992 and 2002 for senior community-dwelling Medicare beneficiaries.
Methods: National Medicare Provider Analysis and Review files for 1992 and 2002 were analyzed.
Results: From 1992 to 2002, rates of inpatient hospital use for treatment of psychiatric illness declined 28%, from 429 to 311 stays per 100,000 eligible beneficiaries, mostly because of reduced hospitalization for depression, and next, for substance use disorder. Inpatient care patterns for patients with schizophrenia and bipolar disorder changed little. Although stays were shorter in 2002 in general, rehospitalization rates remained the same in 2002 as they were in 1992.
Conclusion: Trends in hospitalizations differed by diagnoses, which may be representative of general changes in treatment philosophy during the 1990s.
Similar articles
-
Psychiatric rehospitalization among elderly persons in the United States.Psychiatr Serv. 2008 Sep;59(9):1038-45. doi: 10.1176/ps.2008.59.9.1038. Psychiatr Serv. 2008. PMID: 18757598
-
Inpatient Psychiatric Hospitalization in Texas 1999 to 2010.Tex Med. 2019 May 1;115(5):e1. Tex Med. 2019. PMID: 31042801
-
Inpatient psychiatric treatment of elderly Medicare beneficiaries.Psychiatr Serv. 1998 Sep;49(9):1173-9. doi: 10.1176/ps.49.9.1173. Psychiatr Serv. 1998. PMID: 9735958
-
Health care reform for Americans with severe mental illnesses: report of the National Advisory Mental Health Council.Am J Psychiatry. 1993 Oct;150(10):1447-65. doi: 10.1176/ajp.150.10.1447. Am J Psychiatry. 1993. PMID: 8379547 Review.
-
Medicare Changes in Response to COVID-19: Unintended Effects for Beneficiaries With Mental Illness or Substance Use Disorders.Psychiatr Serv. 2023 Dec 1;74(12):1285-1288. doi: 10.1176/appi.ps.20220502. Epub 2023 Jun 8. Psychiatr Serv. 2023. PMID: 37287226 Review.
Cited by
-
Healthcare cost reductions associated with the use of LAI formulations of antipsychotic medications versus oral among patients with schizophrenia.J Behav Health Serv Res. 2013 Jul;40(3):355-66. doi: 10.1007/s11414-013-9329-z. J Behav Health Serv Res. 2013. PMID: 23579871
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
